| Title : Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotective properties - Arneric_1995_Alzheimer.Dis.Assoc.Disord_9 Suppl 2_50 |
| Author(s) : Arneric SP , Sullivan JP , Decker MW , Brioni JD , Bannon AW , Briggs CA , Donnelly-Roberts D , Radek RJ , Marsh KC , Kyncl J , Williams M , Buccafusco JJ |
| Ref : Alzheimer Disease & Associated Disorders , 9 Suppl 2 :50 , 1995 |
| Abstract : Arneric_1995_Alzheimer.Dis.Assoc.Disord_9 Suppl 2_50 |
| ESTHER : Arneric_1995_Alzheimer.Dis.Assoc.Disord_9 Suppl 2_50 |
| PubMedSearch : Arneric_1995_Alzheimer.Dis.Assoc.Disord_9 Suppl 2_50 |
| PubMedID: 8534424 |
Arneric SP, Sullivan JP, Decker MW, Brioni JD, Bannon AW, Briggs CA, Donnelly-Roberts D, Radek RJ, Marsh KC, Kyncl J, Williams M, Buccafusco JJ (1995)
Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotective properties
Alzheimer Disease & Associated Disorders
9 Suppl 2 :50
Arneric SP, Sullivan JP, Decker MW, Brioni JD, Bannon AW, Briggs CA, Donnelly-Roberts D, Radek RJ, Marsh KC, Kyncl J, Williams M, Buccafusco JJ (1995)
Alzheimer Disease & Associated Disorders
9 Suppl 2 :50